Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add filters








Language
Year range
1.
Arq. bras. oftalmol ; 79(3): 147-150, graf
Article in English | LILACS | ID: lil-787333

ABSTRACT

ABSTRACT Purpose: To analyze the short-term clinical and topographic outcomes in patients with keratoconus after corneal collagen cross-linking treatment (CXL) with dextran-free isotonic riboflavin solution. Methods: In this retrospective case series, 26 eyes from 26 patients with keratoconus were studied. The best corrected visual acuity (BCVA) and refractive and topographic findings were analyzed at a 6-month follow-up. Results: The mean BCVA (Snellen lines) values before and 1, 3, and 6 months after CXL were 0.51 ± 0.2, 0.48 ± 0.2, 0.57 ± 0.2, and 0.64 ± 0.2, respectively, and the difference between the preoperative and 6-month values was statistically significant (p=0.006). The mean spherical equivalent refraction decreased from -5.6 ± 2.4 diopters (D) preoperatively to -5.0 ± 2.1 D, and mean simulated keratometry decreased from 48.5 ± 2.5 D to 47.8 ± 2.6 D at 6 months. (p=0.145 and p=0.001, respectively). In addition, the maximum keratometry decreased progressively and significantly from the preoperative value during follow-up (p=0.003). The central and minimal corneal thicknesses, including those of the epithelium, also decreased from 442.8 ± 25.6 µm and 430.5 ± 23.9 µm preoperatively to 420.7 ± 31.8 µm and 409.3 ± 28.7 µm at the most recent follow-up (p<0.001), respectively. No intraoperative or postoperative complications were observed. Conclusions: CXL with dextran-free isotonic riboflavin solution appears to be a safe treatment alternative for keratoconus and yields sustained short-term improvements in visual acuity, keratometric readings, and corneal thickness. However, long-term results are needed to confirm these outcomes.


RESUMO Objetivo: Analisar os resultados clínicos e topográficos curto prazo após crosslinking (CXL) de córnea com solução isotônica de riboflavina sem dextrano, em pacientes com ceratocone. Método: Estudamos 26 olhos de 26 pacientes com ceratocone, nesta série retrospectiva de casos. Melhor acuidade visual corrigida (BCVA), refração e achados topográficos foram analisados aos 6 meses de acompanhamento. Resultados: BCVA pré-operatória (linhas de Snellen) foi de 0,51 ± 0,2. BCVA após CXL foram de 0,48 ± 0,2, 0,57 ± 0,2 e 0,64 ± 0,2 no 1º, 3º e 6º meses, respectivamente. A diferença entre a BCVA pré-operatória e mais recente foi estatisticamente significativa (p=0,006). O equivalente esférico médio diminuiu de -5,6 ± 2,4 dioptrias (D) no pré-operatório para -5.0 ± 2.1 D e a média da ceratometria simulada diminuiu de 48,5 ± 2,5 D para 47, 8± 2,6 D aos 6 meses. (p=0,145 e p=0,001, respectivamente). A ceratometria máxima diminuiu progressivamente durante o acompanhamento com as mudanças sendo significativamente diferentes do valor pré-operatório (p=0,003). As espessuras corneanas central e mínima, diminuiram de 442,8 ± 25,6 µm e 430,5 ± 23,9 µm para 420,7 ± 31,8 µm e 409,3 ± 28,7 µm, respectivamente, na visita mais recente (p<0,001). Não foram observadas complicações intraoperatórias e pós-operatórias. Conclusões: CXL com solução de riboflavina isotônica sem dextrano parece ser uma opção segura de tratamento para o ceratocone com melhora mantida na acuidade visual, ceratometria e espessura corneana, no curto prazo. Resultados a longo prazo são necessários para confirmar estes resultados.


Subject(s)
Humans , Male , Female , Adolescent , Adult , Young Adult , Riboflavin/therapeutic use , Photosensitizing Agents/therapeutic use , Cornea/drug effects , Cross-Linking Reagents/therapeutic use , Keratoconus/drug therapy , Visual Acuity/drug effects , Reproducibility of Results , Dextrans , Treatment Outcome , Photosensitizing Agents/pharmacology , Statistics, Nonparametric , Cornea/pathology , Corneal Topography , Cross-Linking Reagents/pharmacology , Isotonic Solutions , Keratoconus/pathology
2.
Arq. bras. oftalmol ; 78(6): 348-351, Nov.-Dec. 2015. tab, graf
Article in English | LILACS | ID: lil-768182

ABSTRACT

ABSTRACT Purpose: To quantify the morphological alterations in corneal nerve fibers and cells in patients with pseudoexfoliation syndrome (PEX) and their relationship with the presence of hyperreflective endothelial deposits observed using in vivo confocal microscopy. Methods: One eye each of 37 patients with PEX and 20 age-matched healthy control subjects was evaluated by in vivo corneal confocal microscopy. Patients with PEX were further classified into two groups: those with and without hyperreflective endothelial deposits. We evaluated the densities of basal epithelial cells, anterior and posterior stromal keratocytes, and endothelial cells and structure of sub-basal nerve fibers. Results: The mean anterior and posterior stromal keratocyte and endothelial cell densities and corneal sub-basal nerve plexus variables were significantly lower in patients with PEX compared with those in healthy control subjects. The mean basal epithelial cell density did not significantly differ. Conclusion: Eyes with PEX presented decreased corneal sub-basal nerve plexus variables and cell densities in all corneas, except for the mean basal epithelial cell density. Further, a trend of lower corneal sub-basal nerve plexus measurements in patients with hyperreflective endothelial deposits compared with those without endothelial deposits was observed.


RESUMO Objetivo: Quantificar as alterações morfológicas nas fibras nervosas e nas células da córnea em pacientes com síndrome de pseudoexfoliação (PEX) e sua relação com a presença de depósitos endoteliais hiper-refletivos, observados por meio da microscopia confocal in vivo. Métodos: Trinta e sete olhos de 37 pacientes portadores de PEX e 20 olhos de 20 indivíduos saudáveis, pareados por idade, foram avaliados por meio da microscopia confocal de córnea. Os pacientes com PEX foram classificados em dois grupos: pacientes sem depósitos endoteliais hiper-refletivos e pacientes com depósitos endoteliais hiper-refletivos. Células basais epiteliais, ceratócitos do estroma anterior e posterior, e densidades celulares endoteliais assim como a estrutura das fibras nervosas sub-basais foram avaliadas. Resultados: A média de ceratócitos do estroma anterior e posterior, as densidades celulares endoteliais, bem como as variáveis de plexo nervo sub-basal foram significativamente menores nos pacientes com PEX em comparação com indivíduos saudáveis. A densidade celular epitelial basal não diferiu significativamente. Conclusões: Os olhos com PEX apresentaram diminuição das variáveis do plexo do nervo sub-basal e das densidades celulares em toda a córnea, exceto na camada basal das células epiteliais. Além disso, foi notada uma tendência para valores mais baixos nas variáveis do plexo do nervoso sub-basal em pacientes com depósitos endoteliais hiper-refletivos em comparação àqueles sem depósitos endoteliais.


Subject(s)
Aged , Aged, 80 and over , Female , Humans , Male , Middle Aged , Cornea/pathology , Endothelial Cells/pathology , Exfoliation Syndrome/pathology , Case-Control Studies , Cell Count , Cornea/innervation , Microscopy, Confocal , Nerve Fibers/pathology , Reference Values , Statistics, Nonparametric
3.
Indian J Ophthalmol ; 2012 Jul-Aug; 60(4): 319-321
Article in English | IMSEAR | ID: sea-144862

ABSTRACT

Nanophthalmos is characterized by short axial length, high hypermetropia, thick sclera and a normal-sized crystalline lens. Situs inversus totalis is the mirror image of the normal morphology of the thoracic and abdominal viscera. To the best of our knowledge this is the first report of a nanophthalmic patient with situs inversus totalis. Therefore, we would like to invite the attention of our colleagues to our case and underline the importance of the systemic examination of the nanophthalmic patients to detect systemic malformations and visceral transpositions.


Subject(s)
Child, Preschool , Dextrocardia/diagnosis , Humans , Male , Microphthalmos/diagnosis , Situs Inversus/diagnosis , Tomography, X-Ray Computed
SELECTION OF CITATIONS
SEARCH DETAIL